A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma

Inclusion Criteria

• •1. histologically proven squamous cell carcinoma of the thoracic esophagus
• •2. pathologic stages IIa, IIb, III except T4
• •3. an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2
• •4. no previous history of chemotherapy nor radiotherapy
• •5. an essentially normal clinical laboratory profile (white blood cell count or WBC, \>=4,000 /mm3; hemoglobin or Hb, \>=10g/dl; platelet count or Plt, \>=100,000 /mm3; total serum bilirubin\<=1.2 mg/dl; aspartate aminotransaminase or AST and alanine aminotransaminase or ALT no higher than twice normal; creatinine or CRTN, \<=1.2 mg/dl; creatinine clearance or CCr, \>=60 ml/minute; and arterial oxygen tension or PaO2, \>=65 torr
• •6. oral or written informed consent obtained before randomization